Published in Cancer Weekly, May 25th, 1998
Ultimately, by understanding how both the normal and the damaged gene work, scientists may be able to find ways to interfere with the development of cancer.
Charles Brenner, PhD, assistant professor of microbiology and immunology, and a member of Jefferson's Kimmel Cancer Center, and his colleagues at the University of Texas in San Antonio, and at the University of Sheffield in England have distinguished between potential mechanisms by which the FHIT...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.